Cadillac Keeping Apple Carplay/Android Auto for Foreign Markets, Not U.S.
Specifically, Cadillac EVs sold in Australia and New Zealand will be equipped with the software, according to the Australian outlet Car Expert.
Apart from the Cadillac Lyriq, which debuted before GM shifted away from phone mirroring, Cadillac's EV lineup misses out on the technology.
When it comes to track cars, weekend cars, or maybe even your daily commute, we get it, phone mirroring isn't necessary. But after you've used phone mirroring in your car on one road trip or to find a route that skips seriously backed-up traffic, it's hard to go back. Despite widespread adoption, General Motors—and by extension, Cadillac— has announced a plan to sell its entire electric vehicle portfolio without Apple CarPlay or Android Auto.
That plan may be shifting slightly, as a new report from the Australian outlet Car Expert confirmed that Cadillac's entire EV portfolio for Australia and New Zealand will be equipped with the technology.
View Gallery
Michael Simari
|
Car and Driver
"All Cadillac Lyriq, Lyriq-V, Vistiq, and Optiq vehicles coming to Australia and New Zealand will offer Cadillac Connected Services as well as wireless smartphone projection, which is currently available in Lyriq models (i.e., Apple CarPlay and Android Auto)," a GM spokesperson told the outlet.
View Gallery
Cadillac
In a statement to Car and Driver, Cadillac was not forthcoming about whether or not the change in course for Australia and New Zealand would have any impact on the North American market. "The features available in our infotainment systems vary by region based on local network capabilities and OnStar service availability," a Cadillac spokesperson told C/D. "Ultimately, we're working toward a consistent global platform that will offer integrated native features, including entertainment, charging, navigation, and voice commands. In Australia and New Zealand, phone projection is currently available in select vehicles."
As things stand in the U.S., the only electric Cadillac equipped with Apple CarPlay and Android Auto is the Lyriq, which made its debut ahead of GM's announcement. The news also raises questions about how Cadillac will proceed in Europe, where the automaker is currently pushing for an increased presence.
Jack Fitzgerald
Associate News Editor
Jack Fitzgerald's love for cars stems from his as yet unshakable addiction to Formula 1.
After a brief stint as a detailer for a local dealership group in college, he knew he needed a more permanent way to drive all the new cars he couldn't afford and decided to pursue a career in auto writing. By hounding his college professors at the University of Wisconsin-Milwaukee, he was able to travel Wisconsin seeking out stories in the auto world before landing his dream job at Car and Driver. His new goal is to delay the inevitable demise of his 2010 Volkswagen Golf. Read full bio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
ASX Penny Stocks To Watch With Market Caps Under A$200M
As the Australian market faces a challenging week with futures down and global tariff tensions looming, investors are keenly observing potential opportunities. Despite its somewhat outdated name, the concept of penny stocks remains relevant for those interested in smaller or newer companies that might offer substantial value. By focusing on firms with solid financial foundations and growth potential, investors can uncover hidden gems within this sector. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.40 A$114.64M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.03 A$95.76M ★★★★★★ GTN (ASX:GTN) A$0.57 A$108.68M ★★★★★★ IVE Group (ASX:IGL) A$2.95 A$454.84M ★★★★★☆ West African Resources (ASX:WAF) A$2.35 A$2.68B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.775 A$469.33M ★★★★★★ Regal Partners (ASX:RPL) A$2.92 A$981.78M ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$360M ★★★★★★ Austco Healthcare (ASX:AHC) A$0.37 A$134.79M ★★★★★★ CTI Logistics (ASX:CLX) A$1.86 A$149.81M ★★★★☆☆ Click here to see the full list of 460 stocks from our ASX Penny Stocks screener. Here's a peek at a few of the choices from the screener. CleanSpace Holdings Simply Wall St Financial Health Rating: ★★★★★☆ Overview: CleanSpace Holdings Limited designs, manufactures, and sells respiratory protection products and services for healthcare and industrial markets globally, with a market cap of A$59.48 million. Operations: The company generates revenue of A$17.61 million from its respiratory products segment. Market Cap: A$59.48M CleanSpace Holdings, with a market cap of A$59.48 million, is navigating the challenges of being unprofitable while generating A$17.61 million in revenue from its respiratory products. Despite its negative return on equity and increasing losses over the past five years, it has managed to reduce its debt-to-equity ratio significantly from 51.9% to 14.8%. The company's short-term assets comfortably cover both short- and long-term liabilities, indicating financial stability in the near term. However, the management team lacks extensive experience with an average tenure of 1.9 years, which could impact strategic execution moving forward. Click to explore a detailed breakdown of our findings in CleanSpace Holdings' financial health report. Gain insights into CleanSpace Holdings' future direction by reviewing our growth report. Sandon Capital Investments Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sandon Capital Investments Limited is a publicly owned investment manager with a market capitalization of A$129.27 million. Operations: The company's revenue is derived entirely from Investing Activities, totaling A$23.02 million. Market Cap: A$129.27M Sandon Capital Investments, with a market cap of A$129.27 million, shows financial resilience as its short-term assets (A$167.4M) exceed both short- and long-term liabilities. The company's net profit margins have improved to 70.7%, although it faced negative earnings growth over the past year, contrasting with the industry average growth of 23.4%. Its debt is not well covered by operating cash flow but remains manageable due to more cash than total debt and strong interest coverage by EBIT (9.1x). Despite a low return on equity at 12.6%, its price-to-earnings ratio suggests it may be undervalued compared to the broader Australian market. Dive into the specifics of Sandon Capital Investments here with our thorough balance sheet health report. Explore historical data to track Sandon Capital Investments' performance over time in our past results report. Shaver Shop Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Shaver Shop Group Limited operates as a retailer of personal care and grooming products in Australia and New Zealand, with a market cap of A$193.90 million. Operations: The company's revenue is primarily generated through retail store sales of specialist personal grooming products, amounting to A$218.14 million. Market Cap: A$193.9M Shaver Shop Group Limited, with a market cap of A$193.90 million, operates debt-free and demonstrates financial stability as its short-term assets (A$62.1M) exceed both short- and long-term liabilities. The company has experienced negative earnings growth over the past year (-6.1%), yet forecasts suggest a 7.96% annual growth in earnings moving forward. Despite a decline in net profit margins from 7.1% to 6.7%, Shaver Shop's seasoned management team and high-quality past earnings contribute to its resilience in the market, trading at 54.3% below estimated fair value without significant shareholder dilution recently observed. Click here to discover the nuances of Shaver Shop Group with our detailed analytical financial health report. Evaluate Shaver Shop Group's prospects by accessing our earnings growth report. Summing It All Up Click here to access our complete index of 460 ASX Penny Stocks. Ready For A Different Approach? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CSX ASX:SNC and ASX:SSG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Hypebeast
43 minutes ago
- Hypebeast
Meet The Sculptural New Sneaker from Above The Clouds x ASICS
Summary Above The Cloudscontinues to shape the Australian streetwear landscape with its latest collaboration alongsideASICSSportStyle: theGEL-QUANTUM 360 I. The sneaker fuses performance-grade tech with a deliberately fractured aesthetic. The silhouette is assertively sculptural, anchored by an extended lace system, reinforced toe cap and bonded mesh layering. Visually, it resists symmetry, instead inviting motion and tension through unexpected contours and asymmetrical lines. This isn't just footwear, it's a manifesto against sameness. The design is a clear evolution for Above The Clouds, a Sydney-born fashion institution known for blending minimalist retail architecture with high-concept curation. Since its founding in 2010—and following the opening of itsMelbourne flagshipat 80 Collins Street in 2025—Above The Clouds has become synonymous with progressive taste and global perspective. Priced at $320 AUD (approx. $208 USD), the GEL-QUANTUM 360 I arrives in two striking colourways: 'Soft Yellow/Brisket Red' and 'Soft Yellow/Black.' The exclusive Australian release has already dropped at Above The Clouds, with a global rollout on August 2 viaASICSand stockists likeKITH,Dover Street MarketandAtmos.
Business Wire
6 hours ago
- Business Wire
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
LAS VEGAS--(BUSINESS WIRE)--Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced the development of new product formulations designed to accelerate deep tissue regeneration through enhanced scaffolding facilitation and cell proliferation. Building on its patented QBx™ technology, Regenerex will now incorporate ovine nano-collagen into its wound healing protocols. This highly refined biomaterial, due to its ultra-small molecular size, provides an ideal scaffolding matrix to support and accelerate cellular growth, making it especially beneficial in cases requiring deeper tissue regeneration. As part of this strategic advancement, Regenerex has entered into a licensing agreement with Holista Colltech Ltd. ('Holista'), a globally recognized producer of high-purity ovine collagen. Holista's collagen is derived from ethically sourced, disease-free Australian sheep, produced under Australia's rigorous animal health standards. 'Ovine collagen represents a significant step forward in wound care innovation,' said Greg Pilant, CEO of Regenerex Pharma, Inc. 'Unlike traditional mammalian sources such as bovine or porcine collagen, ovine nano-collagen is not only safer—avoiding concerns like mad cow disease—but also more culturally and religiously acceptable in many global markets.' This collaboration allows Regenerex to bring cutting-edge, biologically advanced wound care solutions to both U.S. and international markets. The integration of ovine nano-collagen with Regenerex's QBx™ technology reflects the company's commitment to providing safe, effective, and inclusive wound healing options. About Regenerex Pharma, Inc. The Mission at Regenerex Pharma, Inc. is to provide the next historical solution in human health crises by solving chronic wound closure and reducing amputations resulting from the stalled healing process in chronic wounds. Regenerex's products treat diabetic foot ulcers, venous ulcers, burns, and pressure ulcers, and heal 95% of chronic wounds in 90 days or less using advanced proprietary woundcare products, proven protocols, and proprietary EMR systems. More information about the Company may be found at About Holista Colltech Ltd. Holista Colltech Ltd. is a global leader in the production of high-purity ovine collagen, leveraging Australia's strict biosecurity standards and ethical sourcing practices. The company is committed to sustainable health innovations and the development of premium-grade natural ingredients for medical and consumer applications. More information about the Company may be found at Notice regarding forward-looking statements This press release contains forward-looking statements that may be subject to various risks and uncertainties. Such forward-looking statements are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and may include statements regarding our future financial performance or results of operations, including expected revenue growth. Unless otherwise required by law, we undertake no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise after the date of this press release. Additional information concerning risks and uncertainties that would cause actual results to differ materially from those projected or suggested in the forward-looking statements can be found in the reports that we have filed with the Securities and Exchange Commission.
